Corruption in South Asia’s healthcare systems is more than a governance issue. From manipulated procurement and bribery to substandard medicines and fraudulent healthcare practices, corruption is putting public health and lives at risk.

COVID-19 exposed critical weaknesses in health systems across low-income countries, raising difficult questions about privatisation, public-sector capacity, regulation, transparency and the future of universal health coverage.